2011 Steep Hill was selected to serve as a
Mendocino County 9.31 inspector. The company inspected cannabis gardens in order to establish compliance with County law.
2013 Steep Hill served on a team that was contracted to consult the
Washington State Liquor and Cannabis Board on implementation of its adult-use legal cannabis program. In July 2013, Steep Hill Lab Inc. merged with Halent Scientific Inc. to form Steep Hill Halent Lab Inc.
2014 In November 2014, Steep Hill and
University of Technology Jamaica signed a
Memorandum of Understanding, initiating a three-year partnership. This partnership furthers advanced research efforts to examine the scientific and medicinal properties and potential of the cannabis plant with the acquisition of a Steep Hill's QuantaCann2 cannabis testing machinery. Steep Hill expanded its lab locations to
Washington state.
2015 Steep Hill announced a partnership with the cannabis lifestyle website
Leafly for the debut of its Strain Fingerprint product. Steep Hill expanded its lab locations to include
New Mexico.
2016 Steep Hill announced significant
East Coast expansion of
licensee lab locations, including new locations in
Pennsylvania,
Washington, D.C., and
Maryland, as well as into
Alaska. The lab obtained approval to operate in Maryland in 2017. During a 30-day period ending on Oct. 10, 2016, Steep Hill performed
quantitative pesticide testing of California-produced cannabis samples, reporting that 84.3% of samples submitted tested positive for pesticide residue, failing to meet the criteria of Oregon's
pesticide regulations. Steep Hill adopts PathogenDx technology for performing commercial cannabis microbial testing to California requirements, deploying January 2017. The work of Steep Hill's cannabis
genomics research division was the subject of a 2016 profile in
Wired magazine.
2017 In August 2017, Steep Hill closed a two million dollar funding round to support its 2018 growth. Steep Hill's Dr. Reggie Gaudino, Ph.D., Vice President of Science, Genetics, and Intellectual Property, provided
testimony before the Sixth Meeting Of the New Mexico Legislative
Health and Human Services Committee, "There Is No
FDA In Cannabis Testing, Therefore, Safe Cannabis for Patients is Left to the States States Must Respond on Behalf of Patients." In November 2017, Steep Hill announced a strategic alliance with New Frontier Data to offer intelligence reporting, data analysis, technology, and scientific expertise to governmental agencies in European Union member countries. Steep Hill Alaska, one of two testing labs in the state, reported inconsistencies in potency results from different labs, resulting in the formation of a committee to look at issues regarding the testing of cannabis products in Alaska. Through a partnership with Canada's
First Nations Pontiac Group, Steep Hill expands to offer full service cannabis testing and quality assurance to
Canada. ==References==